TCTR20210216004
Completed
Not Applicable
tility of the enzyme-linked immunospot interferon-gamma-release assay to predict the risk of infection in kidney transplant recipients
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Infection in kidney transplant recipients
- Sponsor
- Ramathibodi Hospital
- Enrollment
- 100
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •All kidney transplant recipients
Exclusion Criteria
- •Those who refused to join the study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Exploring the utility of enzyme-linked immunospot assays in previous COVID-19 and SARS-CoV-2 vaccinated individualsCOVID-19JPRN-UMIN000049834The Jikei University School of Medicine30
Active, not recruiting
Phase 4
rine Interferon Inducible Protein-10 Guided Treatment to Reduce Lupus Nephritis FlaresSystemic lupus erythemoatosus Lupus nephritisSystemic lupus erythemoatosusLupus nephritisUrine interferon inducible protein-10Preemptive immunosuppressive treatmentTCTR20190517004ational Science and Technology Development Agency216
Active, not recruiting
Phase 1
Antiviral and Immunomodulatory Interferon-Beta in high-risk COVID-19 patientsSARS-CoV 2 infection characterized by a National Early Warning Score lower or equal to 2 and symptoms present for less than 7 daysMedDRA version: 23.0Level: LLTClassification code 10053983Term: Corona virus infectionSystem Organ Class: 100000004862MedDRA version: 20.0Level: PTClassification code 10070255Term: Coronavirus test positiveSystem Organ Class: 10022891 - InvestigationsTherapeutic area: Diseases [C] - Virus Diseases [C02]EUCTR2020-003872-42-ITIstituto di Farmacologia Traslazionale - CNR60
Completed
Not Applicable
Interferon (IFN) induction followed by PEG-interferon combined with ribavirin and amantadine for treatment of naive chronic hepatitis C patients with genotype 1 or 4Hepatitis C virus (HCV)Infections and InfestationsChronic viral hepatitisISRCTN59358441Academic Medical Centre (AMC) (Netherlands)58
Recruiting
Not Applicable
Role and mechanism of type I interferon in the pathogenesis of anti-MDA5 antibody-positive dermatomyositisAnti-MDA5 antibody-positive dermatomyositisJPRN-UMIN000049776Chiba University150